Latest Partnerships News

Morella Corporation has identified 12 new high-priority lithium exploration targets at its Mallina project in Western Australia through a detailed ground gravity survey, setting the stage for further drilling and sampling.

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

Ardea Resources has completed a major infill drilling campaign at its Goongarrie South deposit, confirming premium nickel-cobalt-scandium mineralisation that underpins its Definitive Feasibility Study. The results reinforce the project’s position as Australia’s largest nickel-cobalt resource.

Everlast Minerals Ltd has issued a Replacement Prospectus for a $4-6 million ASX IPO to fund its mineral sands projects in Bangladesh, focusing on advancing the Gaibandha project towards commercial production.

ChemX Materials Limited has entered voluntary administration following a turbulent quarter marked by convertible note amendments, a trading suspension, and ongoing funding challenges.

1414 Degrees has addressed a sharp rise in its share price and trading volume, attributing the market interest to recent climate policy recommendations and ongoing commercial efforts.

Echo IQ has completed its presentation to the CPT Editorial Panel for a Category III CPT code for EchoSolv AS, with a decision expected from the American Medical Association in the coming weeks. Meanwhile, the company is advancing US deployments and FDA clearance efforts.

Scout Security reported a significant 62% reduction in operating cash outflows for Q3 FY2025, while advancing a potential acquisition and partnership opportunities following CES. The company’s cash position remains tight, prompting ongoing capital raising efforts.

Elanor Investors Group is set to reclaim over 12 million stapled securities from Challenger’s Fidante subsidiary as part of unwinding their strategic partnership, reshaping ownership stakes and signaling a new chapter for the funds manager.

Island Pharmaceuticals has won a crucial FDA Type C meeting to discuss fast-tracking its antiviral Galidesivir for Marburg virus treatment, with written feedback expected by November.

Swift Networks secures a landmark Master Services Agreement with Opal HealthCare to deploy its innovative Swift TV platform across multiple aged care communities, marking a significant step in aged care technology integration.

Lunnon Metals has formalized an Ore Purchase Agreement with Gold Fields subsidiary St Ives Gold Mining, setting the stage for development of the high-grade Lady Herial gold deposit. The agreement outlines a 70, 30 free cash flow split and awaits shareholder and regulatory approvals.